TribLIVE

| Business


 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

J&J wins U.S. approval for TB tablet

JNJ $70.10 +$0.62

at close on MONDAY

By Anna Edney C.2012 Bloomberg News
Monday, Dec. 31, 2012, 10:30 p.m.
 

Johnson & Johnson won regulatory approval for its tuberculosis tablet Sirturo, the first drug in 40 years that provides a new way to treat the contagious lung infection.

The Food and Drug Administration cleared Sirturo to be added to therapies for use by adults whose illness is resistant to multiple medicines, the New Brunswick, N.J.- based company said Monday.

While tuberculosis was once the leading cause of death in the nation, the drug-resistant version of the illness affected about 98 people last year, according to the Centers for Disease Control and Prevention.

 

 
 


Show commenting policy

Most-Read Business Headlines

  1. Range Resources to pay $4.15M fine, close old gas drilling impoundments
  2. Post-IPO, Alibaba plans global expansion
  3. Five things you should know about Alibaba’s leadership
  4. 5 Facebook settings to change now
  5. Brighter economy drives up holiday hiring plans
  6. Home construction plunges more than 14% in August
  7. Net worth in U.S. reaches record high
  8. Chevron gets first OK from Pa. sustainable drilling group
  9. Positive economic news pushes Dow, S&P 500 to record levels
  10. Bayer to spin off plastics unit as separate company; employment to remain stable
  11. Bayer plastics unit may be gone
Subscribe today! Click here for our subscription offers.